Everolimus Isomer C(908340-97-6)
- Name: Everolimus Isomer C
- Synonyms:Everolimus Isomer C;DP7PN8Y6FC;908340-97-6;(8S,11S,14R,15E,17R,18R,20R,22S,23E,25E,27E,29S,31S,34R)-1,17-dihydroxy-11-[(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl]-18,29-dimethoxy-14,16,20,22,28,34-hexamethyl-10,36-dioxa-3-azatricyclo[29.4.1.03,8]hexatriaconta-15,23,25,27-tetraene-2,9,13,19,35-pentone;Rapamycin, 9,14-deepoxy-15-deoxo-14-deoxy-9,15-epoxy-15-hydroxy-42-O-(2-hydroxyethyl)-14-oxo-;UNII-DP7PN8Y6FC;SCHEMBL14457940;9,14-Deepoxy-15-deoxo-14-deoxy-9,15-epoxy-15-hydroxy-42-O-(2-hydroxyethyl)-14-oxorapamycin
- Molecular Formula:C53H83NO14
- Molecular Weight:958.2
- CAS Registry Number:908340-97-6
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.908340-97-6 Everolimus Related Compound 1
Assay:95%+ or 98%+ Application:for drug impurity for drug standards,for drug research and development銆侱rug impurity reference, drug standard, analytical chemistry, standard substance, organic chemical synthesis, chemical custo...
Min. Order:25Milligram
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)] CAS No.908340-97-6 Everolimus Impurity F
Assay:99% Appearance:white powder Package:25kg,50kg,180kg,200kg,250kg,1000kg锛宑ustomization Storage:Keep it in dry,shady and cool place Transportation:by express or by sea Application:Pharma;Industry;Agricultural;chemical reaserch
Min. Order:0
Supplier:Wuhan Circle Star Chem-medical Technology co.,Ltd. [
China (Mainland)] CAS No.908340-97-6 Everolimus Isomer C
Assay:80% Appearance:Solid powder Application:For research use only.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 872726-16-4/Ibuprofen eugenol ester
- 872423-56-8/2-(2,5-Diphenyl-2H-pyrazol-3-yl)-7,8-dihydro-6H-quinolin-5-one
- 216691-88-2/7-Chloro-1,3-dihydro-5-(4-methoxyphenyl)-1-methyl-3-(2-naphthalenylmethyl)-2H-1,4-benzodiazepin-2-one
- 867351-47-1/1-(2-Aminophenyl)-3-[({4-[2-(methylsulfanyl)-6-phenylpyrido[2,3-d]pyrimidin-7-yl]phenyl}methyl)amino]propan-1-one
- 870992-80-6/4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6,6-dibromo-3,3-dimethyl-7-oxo-, [[[(tetrahydro-2H-pyran-4-yl)oxy]carbonyl]oxy]methyl ester, 4,4-dioxide, (2S,5R)-
- 869895-82-9/(1R,3R,4R)-3-propyl-2,5-diazabicyclo[2.2.1]heptane
- 51552-85-3/1-Acetyl-1,2,3,4-tetrahydroquinoline-6-carboxylic acid
- 882055-35-8/2-Bromo-7-chloro-6-fluorobenzothiazole
- 742072-74-8/1,3-Benzodioxole, 5-((((1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl)oxy)methyl)-
- 70010-95-6/{[(6-Methoxypyridin-3-yl)amino]methylene}bis(phosphonic acid)
- 1147011-84-4/ORG-25935 free base
- 868962-25-8/2-chloro-N-[({2-[2-(dimethylamino)ethyl]-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-5-yl}amino)carbonyl]acetamide
- 907539-79-1/2-[(3s,4r)-4-{[(3,4-Dichloro-5-Methyl-1h-Pyrrol-2-Yl)carbonyl]amino}-3-Fluoropiperidin-1-Yl]-1,3-Thiazole-5-Carboxylic Acid
- 505031-78-7/(-)-(4S)-3-(4-Chlorophenyl)-N-methyl-4-phenyl-N'-((piperidin-1-yl)sulfonyl)-4,5-dihydro-1H-pyrazole-1-carboxamidine
- 1809096-97-6/Elzasonan metabolite M3
- 120373-67-3/Nobiprostolan
- 444093-81-6/Lidocaine and tetracaine
- 876610-25-2/Dichapetalin I
- 881911-38-2/L-Tyrosine, 3-[(1,1-dimethylethoxy)carbonyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-, 1,1-dimethylethyl carbonate (ester)
- 908340-97-6/Everolimus Isomer C
- 692764-76-4/1,2,5-Thiadiazolidin-3-one, 5-(4'-methyl[1,1'-biphenyl]-4-yl)-, 1,1-dioxide
- 705263-29-2/6-[2-(6-methyl-pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]-1Hbenzoimidazole
- 148214-47-5/Pyrrolo[3,4-e]-1,3-thiazine-5,7(6H,7aH)-dione, 2,6-diphenyl-, (R)-
- 121250-22-4/3-Thiopheneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 3-(dimethylamino)propyl ester, (S)-
- 153836-96-5/Ethanol, 2-(benzo[f]pyrido[2',3':3,4]pyrrolo[2,1-a][2,7]naphthyridin-8-yloxy)-
- 61523-80-6/8-Hydroxyclomipramine
- 253342-66-4/Secofentanyl
- 155632-44-3/Thieno[3,4-c]thiophene-5-SIV-4,6-dicarbonitrile, 1,3-dibromo-
- 128305-92-0/2-(4-Fluorophenyl)-4-(3-trifluoromethylphenyl)-5-methoxypyrimidine
- 153559-85-4/4-[1-(1,1,2,3,3,6-Hexamethyl-indan-5-yl)-vinyl]-benzoic acid